PharmAthene to Host Second Quarter 2009 Conference Call and Webcast on Thursday, August 13, 2009
... ANNAPOLIS, Md., Aug. 6 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: pip ) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that its financial results for the ...PharmAthene Reports First Quarter 2009 Financial and Operational Results
... ANNAPOLIS, Md., May 15 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, today reported financial and operational results f...PharmAthene Announces New Date for First Quarter 2009 Conference Call and Webcast
... ANNAPOLIS, Md., May 8 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: pip ) a biodefense company developing medical countermeasures against biological and chemical threats, announced a date change for its first quarter 2009 ...PharmAthene to Host First Quarter 2009 Conference Call and Webcast on Thursday, May 14, 2009
... ANNAPOLIS, Md., May 7 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: pip ) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that its financial results for the ...PharmAthene Announces $5.5 Million Public Equity Offering
... ANNAPOLIS, Md., March 24 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that certain institutional investo...PharmAthene To Host Year-End 2008 Earnings Conference Call and Webcast on Monday, March 30, 2009
... ANNAPOLIS, Md., March 19 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that its financial results for the ...PAREXEL Experts to Present Leading Insights at Drug Information Association 21st Annual Euromeeting
...atric Investigation Plan (PIP) Advisory from PAREXEL Consulting, with an update and guidance on how biopharmaceutical companies should address the new pip requirements, will be provided at PAREXEL's Booth #1522 . PAREXEL experts will also be available at the booth to hold exclusive executive briefings w...PharmAthene to Host Third Quarter 2008 Conference Call and Webcast on Thursday, November 13, 2008
... ANNAPOLIS, Md., Nov. 6 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE: pip ) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that its financial results for the ...Medarex And PharmAthene Announce New Therapeutic Data for Anthrax Anti-Toxin, Valortim(R)
...ANNAPOLIS, Md., Oct. 28 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX ), a leading monoclonal antibody company, and PharmAthene, Inc. (NYSE: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, today announced results from a pilot study showing...PharmAthene to Present Data for Protexia(R) and Valortim(R) at HHS PHEMCE Stakeholders Workshop 2008
... ANNAPOLIS, Md., Sept. 18 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the Company will present two ...PharmAthene to Present at the UBS Global Life Sciences Conference on Thursday September 25, 2008
... ANNAPOLIS, Md., Sept. 16 /PRNewswire-FirstCall/ -- PharmAthene, Inc., (Amex: pip ) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that David P. Wright, President and...PharmAthene Reports Second Quarter 2008 Financial and Operational Results
... On Track to Reach Significant Milestones in Second Half 2008 ANNAPOLIS, Md., Aug. 12 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, today reported financial and operational results f...Lord Lewis Moonie to Serve as Special UK Government Advisor to PharmAthene
...ies for the Company's Medical Countermeasures ANNAPOLIS, Md., Aug. 11 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, today announced that Lord Lewis Moonie has joined ...PharmAthene Appoints Jordan P. Karp, J.D. Senior Vice President and General Counsel
...ANNAPOLIS, Md., July 10 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ) a biodefense company specializing in the development and commercializatio...sion into broader markets." About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its allies...PharmAthene Reports First Quarter 2008 Financial Results
... ANNAPOLIS, Md., May 13 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ) a biodefense company developing medical countermeasures against biologica..., or until June 13, 2008. About PharmAthene, Inc. PharmAthene's (Amex: pip ) mission is to be the premier company worldwide specializing in the develo...PharmAthene to Host First Quarter 2008 Conference Call and Webcast on Tuesday, May 13, 2008
... ANNAPOLIS, Md., May 6 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ) a biodefense company developing medical countermeasures against biologica...pproximately June 13, 2008. About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed in March 2001 with a mission to become the premier company wor...PharmAthene Closes Acquisition of Avecia Biodefense Vaccines Business Unit
...IS, Md., April 2, 2008 /PRNewswire-FirstCall/ -- PharmAthene, Inc., (Amex: pip ) a biodefense company specializing in the development and commercializatio...e against anthrax threats." About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its allies...PharmAthene Reports Year-End 2007 Financial Results
...NNAPOLIS, Md., March 31 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ) a biodefense company developing medical countermeasures against biologica...proximately April 30, 2008. About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its allies...PharmAthene Year-End 2007 Earnings Conference Call and Webcast Scheduled for Monday, March 31, 2008
...NAPOLIS, Md., March 24 /PRNewswire-FirstCall/ -- PharmAthene, Inc., (Amex: pip ) a biodefense company developing medical countermeasures against biologica...ys, or until April 30, 2008. About PharmAthene, Inc PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its allies...PharmAthene to Delay Release of Full Year 2007 Financial Results
...NNAPOLIS, Md., March 20 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ) a biodefense company developing medical countermeasures against biologica...on announced earlier today. About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its allies...PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia
...e website. The webcast will be available for 30 days, or until approximately Thursday, April 17, 2008. About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its allies by developing and commercializing medical countermeasures against biologic...PharmAthene to Present at the Cowen and Company 28th Annual Health Care Conference
...NAPOLIS, Md., March 10 /PRNewswire-FirstCall/ -- PharmAthene, Inc., (Amex: pip ) a biodefense company developing medical countermeasures against biologica... Jurchison at 410-269-2610. About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its allies...PharmAthene to Present at the BIO CEO & Investor Conference 2008
...ANNAPOLIS, Md., Feb. 6 /PRNewswire-FirstCall/ -- PharmAthene, Inc., (Amex: pip ) a biodefense company developing medical countermeasures against biologica... Jurchison at 410-269-2610. About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its allies...Technology changing for better, Coburn says
... Madison, Wis. - pip Coburn offers a different framework for selling products to what he calls, in a tongue-in-cheek manner, "real humans." And given his forecasting credi...